134 related articles for article (PubMed ID: 15763367)
1. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis.
Singh N; Mishra PK; Kapil A; Arya KR; Maurya R; Dube A
J Ethnopharmacol; 2005 Apr; 98(1-2):83-8. PubMed ID: 15763367
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani.
Lakshmi V; Pandey K; Kapil A; Singh N; Samant M; Dube A
Phytomedicine; 2007 Jan; 14(1):36-42. PubMed ID: 17190644
[TBL] [Abstract][Full Text] [Related]
3. Glycolipids and other constituents from Desmodium gangeticum with antileishmanial and immunomodulatory activities.
Mishra PK; Singh N; Ahmad G; Dube A; Maurya R
Bioorg Med Chem Lett; 2005 Oct; 15(20):4543-6. PubMed ID: 16099649
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
Sharma P; Singh N; Garg R; Haq W; Dube A
Peptides; 2004 Nov; 25(11):1873-81. PubMed ID: 15501518
[TBL] [Abstract][Full Text] [Related]
5. Momordicatin purified from fruits of Momordica charantia is effective to act as a potent antileishmania agent.
Gupta S; Raychaudhuri B; Banerjee S; Das B; Mukhopadhaya S; Datta SC
Parasitol Int; 2010 Jun; 59(2):192-7. PubMed ID: 20132905
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pam3Cys induced protection on the therapeutic efficacy of miltefosine against experimental visceral leishmaniasis.
Shakya N; Sane SA; Shankar S; Gupta S
Peptides; 2011 Oct; 32(10):2131-3. PubMed ID: 21959258
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
8. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
9. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
Raychaudhury B; Banerjee S; Gupta S; Singh RV; Datta SC
Acta Trop; 2005 Jul; 95(1):1-8. PubMed ID: 15896700
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants.
Tasdemir D; Brun R; Perozzo R; Dönmez AA
Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa.
Das A; Das MC; Das N; Bhattacharjee S
Pharm Biol; 2017 Dec; 55(1):998-1009. PubMed ID: 28173714
[TBL] [Abstract][Full Text] [Related]
12. The effects of aqueous extracts of Desmodium gangeticum DC. (Leguminosae) on the central nervous system.
Jabbar S; Khan MT; Choudhuri MS
Pharmazie; 2001 Jun; 56(6):506-8. PubMed ID: 11446174
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis.
Singh N; Kumar A; Gupta P; Chand K; Samant M; Maurya R; Dube A
Parasitol Res; 2008 Feb; 102(3):561-5. PubMed ID: 18080140
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of calceolarioside A against experimental visceral leishmaniasis.
Poddar A; Banerjee A; Ghanta S; Chattopadhyay S
Planta Med; 2008 Apr; 74(5):503-8. PubMed ID: 18543147
[TBL] [Abstract][Full Text] [Related]
15. An ethnomedicinal, phytochemical and pharmacological profile of Desmodium gangeticum (L.) DC. and Desmodium adscendens (Sw.) DC.
Rastogi S; Pandey MM; Rawat AK
J Ethnopharmacol; 2011 Jun; 136(2):283-96. PubMed ID: 21530632
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis.
Dube A; Singh N; Saxena A; Lakshmi V
Parasitol Res; 2007 Jul; 101(2):317-24. PubMed ID: 17294216
[TBL] [Abstract][Full Text] [Related]
18. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
[TBL] [Abstract][Full Text] [Related]
19. Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters.
Murthy PK; Dixit S; Gaur RL; Kumar R; Sahoo MK; Shakya N; Joseph SK; Palne S; Gupta S
Acta Trop; 2008 May; 106(2):81-9. PubMed ID: 18329620
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plant extracts for antileishmanial activity using a mechanism-based radiorespirometric microtechnique (RAM).
Iwu MM; Jackson JE; Tally JD; Klayman DL
Planta Med; 1992 Oct; 58(5):436-41. PubMed ID: 1470668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
